MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Clinical trial NCT03226119 · COMPLETED

Trial details

NCT number: NCT03226119
Sponsor: MP Biomedicals, LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HTLV-I Infections HTLV-II Infections Human T-lymphotropic Virus 1 Human T-lymphotropic Virus 2 HTLV I Associated T Cell Leukemia Lymphoma HTLV I Associated Myelopathies

Start date: 2018-01-15
Primary completion: 2018-07-10
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.